Cargando…

Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trial

PURPOSE: The sodium-glucose transporter 2 inhibitor (SGLT2i) empagliflozin may reduce the incidence of obstructive sleep apnea (OSA) in patients with type 2 diabetes (T2D) and cardiovascular (CV) disease. This analysis of VERTIS CV, the CV outcome trial for the SGLT2i ertugliflozin conducted in a si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wojeck, Brian S., Inzucchi, Silvio E., Neeland, Ian J., Mancuso, James P., Frederich, Robert, Masiukiewicz, Urszula, Cater, Nilo B., McGuire, Darren K., Cannon, Christopher P., Yaggi, Henry Klar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Sleep Breathing Physiology and Disorders • Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212814/ https://www.ncbi.nlm.nih.gov/pubmed/35596030 http://dx.doi.org/10.1007/s11325-022-02594-2

Ejemplares similares

Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial
por: Cosentino, Francesco, et al.
Publicado: (2022)

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial
por: Cosentino, Francesco, et al.
Publicado: (2020)

Ertugliflozin Delays Insulin Initiation and Reduces Insulin Dose Requirements in Patients With Type 2 Diabetes: Analyses From VERTIS CV
por: Dagogo-Jack, Samuel, et al.
Publicado: (2023)

Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial
por: Cherney, David Z.I., et al.
Publicado: (2022)

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV
por: Dagogo‐Jack, Samuel, et al.
Publicado: (2022)

How does obstructive sleep apnea alter cerebral hemodynamics?
por: Gregori-Pla, Clara, et al.
Publicado: (2023)

Comparative associations of oximetry patterns in Obstructive Sleep Apnea with incident cardiovascular disease
por: Sutherland, Kate, et al.
Publicado: (2022)

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea
por: Fox, Henrik, et al.
Publicado: (2019)

Swallowing and aspiration during sleep in patients with obstructive sleep apnea versus control individuals
por: Kohno, Akane, et al.
Publicado: (2022)

Displacement of the hyoid bone by muscle paralysis and lung volume increase: the effects of obesity and obstructive sleep apnea
por: Kohno, Akane, et al.
Publicado: (2018)

Discovery of genomic loci associated with sleep apnea risk through multi-trait GWAS analysis with snoring
por: Campos, Adrian I, et al.
Publicado: (2022)

The effect of obstructive sleep apnea therapy on cardiovascular autonomic function: a systematic review and meta-analysis
por: Dissanayake, Hasthi U, et al.
Publicado: (2022)

Obstructive sleep apnea is associated with coronary microvascular dysfunction: A systematic review from a clinical perspective
por: Zhang, Rui‐Heng, et al.
Publicado: (2020)

A multicentric validation study of a novel home sleep apnea test based on peripheral arterial tonometry
por: Van Pee, Bart, et al.
Publicado: (2022)

Abnormal brain iron accumulation in obstructive sleep apnea: A quantitative MRI study in the HypnoLaus cohort
por: Marchi, Nicola Andrea, et al.
Publicado: (2022)

Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apnea
por: Baumert, Mathias, et al.
Publicado: (2023)

Assessment of obstructive sleep apnea-related sleep fragmentation utilizing deep learning-based sleep staging from photoplethysmography
por: Huttunen, Riku, et al.
Publicado: (2021)

Correlates of excessive daytime sleepiness in obstructive sleep apnea: Results from the nationwide SESAR cohort including 34,684 patients
por: Ulander, Martin, et al.
Publicado: (2022)

Overnight declarative memory consolidation and non-rapid eye movement sleep electroencephalographic oscillations in older adults with obstructive sleep apnea
por: Teh, Jun Z, et al.
Publicado: (2023)

Improvements in cognitive function and quantitative sleep electroencephalogram in obstructive sleep apnea after six months of continuous positive airway pressure treatment
por: D’Rozario, Angela L, et al.
Publicado: (2022)

Respiratory safety of lemborexant in healthy adult and elderly subjects with mild obstructive sleep apnea: A randomized, double‐blind, placebo‐controlled, crossover study
por: Cheng, Jocelyn Y., et al.
Publicado: (2020)

Effect of adaptive servo ventilation on central sleep apnea and sleep structure in systolic heart failure patients: polysomnography data from the SERVE‐HF major sub study
por: Tamisier, Renaud, et al.
Publicado: (2022)

Determinants of depressive mood in coronary artery disease patients with obstructive sleep apnea and response to continuous positive airway pressure treatment in non‐sleepy and sleepy phenotypes in the RICCADSA cohort
por: Balcan, Baran, et al.
Publicado: (2019)

Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial
por: Cherney, David Z. I., et al.
Publicado: (2021)

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial
por: Dagogo-Jack, Samuel, et al.
Publicado: (2021)

Central apnea and periodic breathing in children with underlying conditions
por: Ghirardo, Sergio, et al.
Publicado: (2021)

Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
por: Budoff, Matthew J., et al.
Publicado: (2021)

Heart and Kidney Outcomes With Ertugliflozin in People with Non-albuminuric Diabetic Kidney Disease: A post hoc Analysis from the Randomized VERTIS CV Trial
por: Cherney, David Z.I., et al.
Publicado: (2022)

Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing
por: Vanderveken, Olivier M, et al.
Publicado: (2013)

Algorithm for automatic detection of self-similarity and prediction of residual central respiratory events during continuous positive airway pressure
por: Oppersma, Eline, et al.
Publicado: (2020)

Self‐reported symptoms of sleep‐disordered breathing and risk of cardiovascular diseases: Observational and Mendelian randomization findings
por: Titova, Olga E., et al.
Publicado: (2022)

In search of a better CPAP interface: A network meta‐analysis comparing nasal masks, nasal pillows and oronasal masks
por: Chen, Li‐Yang, et al.
Publicado: (2022)

Multimodal phenotypic labelling using drug‐induced sleep endoscopy, awake nasendoscopy and computational fluid dynamics for the prediction of mandibular advancement device treatment outcome: a prospective study
por: Van den Bossche, Karlien, et al.
Publicado: (2022)

Effects of oral appliance treatment on inflammatory biomarkers in obstructive sleep apnea: A randomised controlled trial
por: Hedberg, Pär, et al.
Publicado: (2020)

Influence and implications of the renin–angiotensin–aldosterone system in obstructive sleep apnea: An updated systematic review and meta‐analysis
por: Loh, Huai Heng, et al.
Publicado: (2022)

Rapid eye movement sleep apnea and carotid intima thickness in men and women: a SHE‐MUSTACHE cohort study
por: Ljunggren, Mirjam, et al.
Publicado: (2022)

Communication during the initial visit to a CPAP clinic Practitioners’ experiences of facilitators and barriers when talking to patients with obstructive sleep apnea
por: Broström, Anders, et al.
Publicado: (2020)

Sleep apnea pathophysiology
por: Andrisani, Giovanni, et al.
Publicado: (2023)

Obstructive sleep apnea syndrome in non-obese patients
por: Antonaglia, Caterina, et al.
Publicado: (2021)

Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV
por: Strojek, Krzysztof, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gieq4330ka5qm893o56s43234k